Previous close | 2.2900 |
Open | 2.1000 |
Bid | 1.7000 |
Ask | 2.2500 |
Strike | 5.00 |
Expiry date | 2024-10-18 |
Day's range | 2.1000 - 2.2900 |
Contract range | N/A |
Volume | |
Open interest | 19 |
The Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE) to develop bird flu vaccines over increasing fears of widespread transmission of the infection.
Market forces rained on the parade of CureVac N.V. ( NASDAQ:CVAC ) shareholders today, when the analysts downgraded...
CureVac ( NASDAQ:CVAC ) Full Year 2023 Results Key Financial Results Revenue: €53.8m (down 20% from FY 2022). Net loss...